Survival in multiple system atrophy
暂无分享,去创建一个
[1] R. Kahn,et al. Language lateralization in monozygotic twin pairs concordant and discordant for handedness. , 2002, Brain : a journal of neurology.
[2] A. Mosley,et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations , 2005, Neurology.
[3] T Klockgether,et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. , 1998, Brain : a journal of neurology.
[4] N. Quinn,et al. Survival of patients with pathologically proven multiple system atrophy , 1997, Neurology.
[5] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[6] N P Quinn,et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.
[7] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[8] C. Antunes,et al. Color and genomic ancestry in Brazilians , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] Christine Klein,et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.
[10] D. Mash,et al. Causes of death in multiple system atrophy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[11] A. Singleton,et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. , 2005, Brain : a journal of neurology.
[12] G. Filippini,et al. Survival in multiple system atrophy: a study of prognostic factors in 59 cases , 1996, Journal of Neurology.
[13] G. Filippini,et al. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy , 2001, Neurological Sciences.
[14] Andrew J. Lees,et al. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.
[15] P. Pollak,et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.
[16] Y. Abe,et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.
[17] U Nath,et al. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[18] A. Singleton,et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort , 2005, Movement disorders : official journal of the Movement Disorder Society.
[19] J. Nutt,et al. Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics , 2006, Movement disorders : official journal of the Movement Disorder Society.
[20] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[21] Y. Agid,et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease , 2005, Annals of neurology.
[22] J. Volkmann,et al. Recurrent LRRK2 (Park8) mutations in early‐onset Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[23] Tatiana Foroud,et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease , 2005, The Lancet.
[24] M. Canesi,et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor , 2005, Journal of Medical Genetics.